BridgePort Financial Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

BridgePort Financial Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$624K	Buy	1,257 +24	+2%	+$10.6K	0.16%	118
2026 Q1	$551K	Buy	1,233 +24	+2%	+$11.2K	0.16%	118
2025 Q4	$548K	Buy	1,209 +218	+22%	+$94K	0.15%	123
2025 Q3	$388K	Buy	991 +148	+18%	+$61.9K	0.1%	152
2025 Q2	$375K	Buy	843 +50	+6%	+$23K	0.12%	130
2025 Q1	$384K	Sell	793 -1	-0.1%	-$466	0.17%	111
2024 Q4	$377K	Buy	+794	New	+$368K	0.17%	111

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BridgePort Financial Solutions's VRTX Position: Q2 2026 in Review

BridgePort Financial Solutions increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q2 2026, buying an estimated $10.6K and bringing the position to 1,257 shares worth $624K. The position accounts for 0.16% of the portfolio, ranked #118.

BridgePort Financial Solutions first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

BridgePort Financial Solutions held 1,257 shares of Vertex Pharmaceuticals worth $624K as of Q2 2026.
BridgePort Financial Solutions bought 24 Vertex Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
Vertex Pharmaceuticals made up 0.16% of BridgePort Financial Solutions's portfolio in Q2 2026, its #118 holding.
BridgePort Financial Solutions first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on BridgePort Financial Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.